Bailard Inc. Grows Holdings in Cardinal Health, Inc. (NYSE:CAH)

Bailard Inc. boosted its position in Cardinal Health, Inc. (NYSE:CAH) by 3.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,012 shares of the company’s stock after buying an additional 177 shares during the quarter. Bailard Inc.’s holdings in Cardinal Health were worth $711,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC grew its holdings in Cardinal Health by 37.4% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,378 shares of the company’s stock worth $163,000 after acquiring an additional 375 shares in the last quarter. Keynote Financial Services LLC bought a new position in shares of Cardinal Health during the fourth quarter worth about $201,000. Jacobi Capital Management LLC grew its stake in Cardinal Health by 10.6% in the fourth quarter. Jacobi Capital Management LLC now owns 3,365 shares of the company’s stock worth $398,000 after purchasing an additional 322 shares in the last quarter. Fisher Asset Management LLC bought a new stake in Cardinal Health in the fourth quarter valued at about $368,000. Finally, SVB Wealth LLC bought a new stake in Cardinal Health in the fourth quarter valued at about $231,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Argus set a $148.00 target price on shares of Cardinal Health in a research note on Tuesday, February 4th. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and increased their target price for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Morgan Stanley boosted their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st. Finally, Citigroup increased their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $139.36.

Cardinal Health Price Performance

CAH opened at $128.96 on Tuesday. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $132.84. The company has a market capitalization of $31.15 billion, a price-to-earnings ratio of 24.06, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. The business has a 50 day moving average price of $124.96 and a two-hundred day moving average price of $118.40.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.57%. Cardinal Health’s dividend payout ratio (DPR) is 37.69%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.